THEMISMED — Themis Medicare Income Statement
0.000.00%
Last trade - 00:00
- IN₹19.24bn
- IN₹19.91bn
- IN₹3.54bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,838 | 2,016 | 2,307 | 3,946 | 3,543 |
Cost of Revenue | |||||
Gross Profit | 1,048 | 1,270 | 1,435 | 2,261 | 2,194 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,850 | 1,741 | 1,897 | 3,085 | 2,974 |
Operating Profit | -12 | 275 | 409 | 862 | 570 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -126 | 269 | 413 | 953 | 725 |
Provision for Income Taxes | |||||
Net Income After Taxes | -108 | 248 | 357 | 729 | 569 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -107 | 248 | 357 | 729 | 569 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -107 | 248 | 357 | 729 | 569 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.17 | 2.7 | 3.88 | 7.91 | 6.17 |
Dividends per Share |